Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials-Reference-Cited by-同舟云学术

Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials

Published:2017-10 Issue:6 Volume:17 Page:433-440
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Bernardo Antonio,Palumbo Raffaella,Pedersini Rebecca,Rota Caremoli Elena,Gambaro Anna Rita,Ferzi Antonella^ORCID,Riva Francesca^ORCID,Grasso Donatella^ORCID,Danova Marco,Tarenzi Emiliana,Torri Valter,Cazzaniga Marina E.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference16 articles.

1. Taxanes in breast cancer: an update;Conlin;Curr Oncol Rep,2007

2. Taxanes in the first-line chemotherapy of metastatic breast cancer: review;Friedrich;Eur J Gynaecol Oncol,2004

3. Weekly paclitaxel in the adjuvant treatment of breast cancer;Sparano;N Engl J Med,2008

4. The role of taxanes in triple-negative breast cancer: literature review;Mustacchi;Drug Des Devel Ther,2015

5. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer;Gradishar;J Clin Oncol,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inetetamab in combination with rapamycin and chemotherapy for trastuzumab‐treated metastatic human epidermal growth factor receptor 2‐positive breast cancer with abnormal activation of PI3K/Akt/mTOR pathway;Cancer Reports;2023-07-28

2. A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer;BMC Cancer;2021-07-18

3. Drug Delivery Systems of Natural Products in Oncology;Molecules;2020-10-06

4. Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel;Clinical Breast Cancer;2018-12

5. Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project;Cancer Chemotherapy and Pharmacology;2018-11-20